Risk factors for infection after pediatric lung transplantation

Chinyere Onyearugbulem1,2,3, Lauren Williams1,2, Huirong Zhu1,4

  • 1Texas Children's Hospital, Houston, Texas.

Insights

In pediatric lung transplant recipients, prolonged donor ischemic time is a key risk factor for early post-operative infection. Reducing this time may decrease transplant-related complications.

Area of Science:

  • Pediatric transplantation
  • Infectious diseases
  • Critical care medicine

Background:

  • Infection is the primary cause of mortality within the first year after pediatric lung transplantation.
  • Early post-operative sepsis is often under-recognized and under-reported in pediatric lung transplant recipients (LTRs).
  • Limited data exist on the specific risk factors contributing to early infections in this vulnerable population.

Purpose of the Study:

  • To determine the incidence of infection and sepsis in the early post-operative period for pediatric LTRs.
  • To identify significant risk factors associated with early post-operative infection in pediatric LTRs.

Main Methods:

  • Retrospective review of medical records for pediatric LTRs from January 2009 to March 2016.
  • Analysis of microbiology results from post-transplant days 0-7.
  • Sepsis defined using the 2005 International Pediatric Consensus Conference criteria.
  • Evaluation of risk factors including donor/recipient infection history, multi-drug resistant (MDR) infection history, nutritional status, and surgical times.

Main Results:

  • Out of 98 pediatric LTRs, 22 (22%) experienced post-operative infections.
  • Prolonged donor ischemic time (≥7 hours), cardiopulmonary bypass (CPB) time (≥340 minutes), history of MDR infection, and cystic fibrosis diagnosis were associated with infection.
  • Multivariable regression analysis identified prolonged donor ischemic time as the only significant independent risk factor (OR 4.4, 95% CI: 1.34-14.48).

Conclusions:

  • Prolonged donor ischemic time is a significant risk factor for early post-operative infection in pediatric lung transplant recipients.
  • Further research is warranted to explore strategies for reducing donor ischemic time to mitigate post-transplant morbidity.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311